内镜下全覆膜自膨式金属支架联合负压引流治疗术后结直肠癌吻合口瘘并吻合口狭窄
Endoscopic fully covered self-expandable metal stent and vacuum-assisted drainage to treat postoperative colorectal cancer anastomotic stenosis with fistula.
机构信息
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei, China.
出版信息
Surg Endosc. 2023 May;37(5):3780-3788. doi: 10.1007/s00464-022-09831-5. Epub 2023 Jan 23.
BACKGROUND
Digestive tract reconstruction is required after the surgical resection of a colorectal malignant tumor. Some patients may have concomitant anastomotic complications, such as anastomotic stenosis with fistula (ASF), postoperatively. Therefore, we evaluated the efficacy and safety of endoscopic fully covered self-expandable metal stent and homemade vacuum sponge-assisted drainage (FSEM-HVSD) for the treatment of ASF following the radical resection of colorectal cancer.
METHODS
Patients treated with FESM-HVSD were prospectively analyzed and followed up for ASF following colorectal cancer treatment in our medical center from 2017 to 2021 for the observation and evaluation of its safety and efficacy.
RESULTS
Fifteen patients with a mean age of 55.80 ± 11.08 years were included. Nine patients (60%) underwent protective ileostomy. All 15 patients were treated with endoscopic FSEM-HVSD. The median time from the index operation to the initiation of FSEM-HVSD was 80 ± 20.34 days in patients who underwent protective ileostomy versus 11.4 ± 4.4 days in those who did not. The average number of endoscopic treatments per patient was 5.70 ± 1.25 times. The mean length of hospital stay was 27.60 ± 4.43 days. FSEM-HVSD treatment was successful in 13 patients, and no patients had any complications. The follow-up time was 1 year. Twelve of 15 (80%) patients achieved prolonged clinical success after FSEM-HVSD treatment, 1 experienced anastomotic tumor recurrence and underwent surgery again, and 1 patient required balloon dilation for anastomotic stenosis recurrence.
CONCLUSIONS
FSEM-HVSD is an effective, safe, and minimally invasive treatment for ASF following colorectal cancer treatment. This technique could be the preferred treatment strategy for patients with ASF.
背景
结直肠恶性肿瘤手术后需要进行消化道重建。部分患者术后可能合并吻合口并发症,如吻合口狭窄伴瘘(ASF)。因此,我们评估了内镜全覆膜自膨式金属支架联合自制负压海绵引流(FSEM-HVSD)治疗结直肠癌根治术后 ASF 的疗效和安全性。
方法
回顾性分析 2017 年至 2021 年我院收治的 15 例行 FESM-HVSD 治疗的 ASF 患者的临床资料,观察并评估其安全性和疗效。
结果
15 例患者,平均年龄 55.80±11.08 岁。9 例(60%)患者行保护性肠造口。15 例患者均行内镜 FSEM-HVSD 治疗。保护性肠造口患者行 FSEM-HVSD 的时间为(80±20.34)d,无保护性肠造口患者为(11.4±4.4)d。患者平均内镜治疗次数为(5.70±1.25)次。平均住院时间为(27.60±4.43)d。13 例患者 FSEM-HVSD 治疗成功,无患者出现并发症。随访 1 年,15 例患者中 12 例 FSEM-HVSD 治疗后获得长期临床缓解,1 例吻合口肿瘤复发后再次手术,1 例吻合口狭窄复发行球囊扩张。
结论
FSEM-HVSD 是治疗结直肠癌根治术后 ASF 的一种有效、安全、微创的方法。对于 ASF 患者,FSEM-HVSD 可能是首选的治疗策略。